Image

Efficacy Comparison Between Independent Auscultation by Primary Care Physicians and AI-Assisted Auscultation in Large-scale Screening for Congenital Heart Disease: A Cluster Randomized Controlled Trial in China

Efficacy Comparison Between Independent Auscultation by Primary Care Physicians and AI-Assisted Auscultation in Large-scale Screening for Congenital Heart Disease: A Cluster Randomized Controlled Trial in China

Recruiting
18 years and younger
All
Phase N/A

Powered by AI

Overview

This study plans to conduct clinical validation of the model in real clinical settings, comparing it with primary care physicians and specialist physicians to ensure the model's practicality. Through continuous optimization and practice, the study aims to use AI-assisted heart sound auscultation to empower the auscultation capabilities of primary care obstetricians, pediatricians, and non-cardiovascular specialists nationwide. This will not only reduce the missed diagnosis rate and improve the detection rate of existing CHD screenings, but also expand the coverage of current CHD screening networks, incorporating newborns, infants, preschool children, children, and adolescents aged 0-18 years into the screening scope. The study aims to establish a new benchmark in child health management by providing feasible and cost-effective child health management solutions for other developing countries, contributing to global efforts for the health of children.

Eligibility

Inclusion Criteria (Schools):

  • The school is of the type: kindergarten, primary school, junior high school, or senior high school.
  • The school has medical screening facilities and conditions that can support AI-assisted screening.
  • The area where the school is located has at least one primary healthcare institution willing to participate in this trial.
  • The school's management and teaching staff are willing to participate in the study and can cooperate to complete the related screening and data collection work.

Exclusion Criteria (Schools):

  • More than half of the students in the school refuse to participate in the trial.
  • Schools that are unable to complete the study due to severe limitations in geographical location and transportation conditions.
  • Schools lacking medical screening facilities and conditions necessary for the implementation of screening.
  • Areas where there are no primary healthcare institutions willing to participate in this trial.
  • Schools whose management and teaching staff refuse to participate in the study or are unable to cooperate in completing the related screening and data collection work.

Inclusion Criteria (Individuals):

  • Children aged between 0 and 18 years, regardless of gender.
  • Children who agree to undergo echocardiography to determine the presence of congenital heart disease.
  • Individuals who voluntarily participate in this study and sign the informed consent form.

Exclusion Criteria (Individuals):

  • Individuals over the age of 18.
  • Children who are unable to complete echocardiography or do not cooperate with auscultation.
  • Participants who are unable to provide informed consent or are unwilling to comply with the study requirements to provide medical data for further analysis and research.
  • Participants who have received interventional or surgical treatment for CHD.

Study details
    Congenital Heart Disease (CHD)
    Screening Tool
    Artificial Intelligence (AI)
    Cluster Randomized Trial
    Auscultation for Clinical Evaluation

NCT06791109

Kun Sun

15 October 2025

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.